Mindray DS USA of Mahwah, NJ, has launched its new premium M7 ultrasound system in the U.S.
The M7 platform is based on System On Chip (SOC) technology to enhance imaging performance in the compact portable system.
The M7 features include octal-beam imaging technology for temporal resolution and multiple tissue harmonic imaging technologies to improve image quality for technically difficult patients.
Mindray also has introduced an upgrade for its M5 system. The new 3.0 release features full DICOM capability, networking, worklist, query and retrieve, and structured reporting.
The upgrade includes automatic measurement of carotid intima-media thickness and wireless data transfer, but both features are pending regulatory clearance.
Mindray DS USA is a subsidiary of Chinese medical equipment manufacturer Mindray Medical International of Shenzhen.
Related Reading
Mindray's imaging sales edge up, August 10, 2010
Mindray announces American public offering, March 4, 2010
Mindray posts Q4, year-end revenue increases, March 2, 2010
Mindray debuts M5 ultrasound upgrade, December 1, 2009
Mindray names Thompson to VP sales post, September 4, 2009
Copyright © 2010 AuntMinnie.com
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)